Browsing by Author de Souza, Paul

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)Citation
2012Efficacy of erlotinib in patients with advanced Non-small-cell Lung Cancer (NSCLC): Analysis of the Australian subpopulation of the TRUST studyBoyer, Michael; Pavlakis, Nick; Abell, Fiona; de Souza, Paul; Horwood, Keith; Johnston, Michael; Millward, Michael; Rischin, Danny; Stein, Brian; Central Clinical School: Medicine; Northern Clinical School: MedicineEfficacy of erlotinib in patients with advanced Non-small-cell Lung Cancer (NSCLC): Analysis of the Australian subpopulation of the TRUST study, Asia Pacific Journal of Clinical Oncology, vol.8, 3, 2012,pp 248-254
2012Increase in Cholesterol PredictsSsurvival Advantage in Renal Cell Carcinoma Patients Treated with TemsirolimusLee, Chee; Marschner, Ian (Colin); Simes, Robert John; Voysey, Merryn; de Souza, Paul; Egleston, Brian; Hudes, Gary; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreIncrease in Cholesterol PredictsSsurvival Advantage in Renal Cell Carcinoma Patients Treated with Temsirolimus, Clinical Cancer Research, vol.18, 11, 2012,pp 3188-3196
2013Markers of systemic inflammation predict survival in patients with advanced renal cell cancerBrown, Christopher; Gebski, Val; Lee, Chee; Lord, Sarah (Sally); de Souza, Paul; Fox, P; Hudson, M; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreMarkers of systemic inflammation predict survival in patients with advanced renal cell cancer, British Journal of Cancer, vol.109, 1, 2013,pp 147-153
2015p27(Kip1) signaling: Transcriptional and post-translational regulationDong, Qihan; Holst, Jeffrey; Yao, Mu; Bensoussan, Alan; de Souza, Paul; Hnit, Su Su Thae; Li, Zhong; Xie, Chanlu; Central Clinical School: Medicine; Central Clinical School: Centenary Institute; Central Clinical School: Medicinep27(Kip1) signaling: Transcriptional and post-translational regulation, The International Journal of Biochemistry and Cell Biology, vol.68, N/A, 2015,pp 9-14
2016The Potential Value of Immunotherapy in Colorectal Cancers: Review of the Evidence for Programmed Death-1 Inhibitor TherapyToh, James; Chua, Wei; de Souza, Paul; Lim, Stephanie; Ng, Weng; Singh, Puneet; Spring, Kevin; Central Clinical School: MedicineThe Potential Value of Immunotherapy in Colorectal Cancers: Review of the Evidence for Programmed Death-1 Inhibitor Therapy, Clinical Colorectal Cancer, vol.15, 4, 2016,pp 285-291
2013Primary treatment of the prostate improves local palliation in men who ultimately develop castrate-resistant prostate cancerGurney, Howard; Marx, Gavin; Patel, Manish; Won, Andy; de Souza, Paul; Western Clinical School: Medicine (Westmead); Medicine; Western Clinical School: Surgery; MedicinePrimary treatment of the prostate improves local palliation in men who ultimately develop castrate-resistant prostate cancer, BJU International, vol.112, 4, 2013,pp E250-E255
2016Serum human epidermal growth factor 2 extracellular domain as a predictive biomarker for lapatinib treatment efficacy in patients with advanced breast cancerDavies, Lucy; Gebski, Val; Lee, Chee Khoon; Lord, Sarah (Sally); Marschner, Ian; Simes, Robert John; Cameron, David; de Souza, Paul; Di Leo, Angelo; Ellis, Catherine; Geyer, Charles; Johnston, Stephen; Loi, Sherene; Press, Michael F.; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreSerum human epidermal growth factor 2 extracellular domain as a predictive biomarker for lapatinib treatment efficacy in patients with advanced breast cancer, Journal of Clinical Oncology, vol.34, 9, 2016,pp 936-944